Czasopismo Clinical and Experimental Hepatology 2023

Review paper

Porto-sinusoidal vascular disease: a new definition of an old clinical entity

Mislav Barisic-Jaman, Marko Milosevic, Frane Pastrovic, Anita Skrtic, Ivica Grgurevic

Clin Exp HEPATOL 2023; 9, 4: 297-306

DOI: https://doi.org/10.5114/ceh.2023.133107

Abstract View text (PDF)

Review paper

The role of microRNAs in hepatocellular carcinoma: Therapeutic targeting of tumor suppressor and oncogenic genes

Nasim Rahimi Farsi, Bahman Naghipour, Parviz Shahabi, Reza Safaralizadeh, Khalil Hajiasgharzadeh, Narges Dastmalchi, Mohammad Reza Alipour

Clin Exp HEPATOL 2023; 9, 4: 307-319

DOI: https://doi.org/10.5114/ceh.2023.131669

Abstract View text (PDF)

Original paper

Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure

Olga Tronina, Michał Brzdęk, Dorota Zarębska-Michaluk, Beata Lorenc, Justyna Janocha-Litwin, Hanna Berak, Marek Sitko, Dorota Dybowska, Włodzimierz Mazur, Magdalena Tudrujek-Zdunek, Ewa Janczewska, Jakub Klapaczyński, Witold Dobracki, Anna Parfieniuk-Kowerda, Rafał Krygier, Łukasz Socha, Robert Flisiak

Clin Exp HEPATOL 2023; 9, 4: 320-334

DOI: https://doi.org/10.5114/ceh.2023.133307

Abstract View text (PDF)

Original paper

Does amyloid b precursor protein gene expression have a role in diagnosis of biliary atresia?

Salma Abdel Megeed Nagi, Heba Mohamed Abdallah, Abeer Abdelfattah El Gazzar, Bassam Abdel Hakam Ayoub, Mohammed Abdel-Hafez Ali, Marwa Sabry

Clin Exp HEPATOL 2023; 9, 4: 335-343

DOI: https://doi.org/10.5114/ceh.2023.132818

Abstract View text (PDF)

Original paper

Concomitant diverticulosis among patients undergoing liver transplantation. Does it influence the length of hospitalization after the procedure?

Tomasz Menżyk, Lubomir Skladany, Svetlana Adamcova-Selcanova, Janka Vnencakova, Daniela Zilincanova, Natalia Bystrianska, Dorota Hudy, Magdalena Skonieczna, Wojciech Marlicz, Michał Kukla

Clin Exp HEPATOL 2023; 9, 4: 344-350

DOI: https://doi.org/10.5114/ceh.2023.132255

Abstract View text (PDF)

Original paper

Comparison of intravenous terlipressin infusion versus bolus in patients with acute-on-chronic liver failure–acute kidney injury – an open label RCT

Tarana Gupta, Ashank Goel, Naveen Ranga, Sandeep K. Goyal

Clin Exp HEPATOL 2023; 9, 4: 351-358

DOI: https://doi.org/10.5114/ceh.2023.132813

Abstract View text (PDF)

Original paper

Methotrexate-induced hepatotoxicity in rats and the therapeutic properties of vitamin E: a histopathologic and flowcytometric research

Ahmet U. Akman, Zuleyha Erisgin, Sibel Turedi, Yavuz Tekelioglu

DOI: https://doi.org/10.5114/ceh.2023.132251

Abstract View text (PDF)

Original paper

Thrombospondin-2 as a potential noninvasive biomarker of hepatocyte injury but not liver fibrosis in children with MAFLD: A preliminary study

Katarzyna Zdanowicz, Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Monika Kowalczuk-Kryston, Jacek Jamiolkowski, Diana Martonik, Magdalena Rogalska, Dariusz M. Lebensztejn

Clin Exp HEPATOL 2023; 9, 4: 368-374

DOI: https://doi.org/10.5114/ceh.2023.133108

Abstract View text (PDF)

Original paper

The influence of steroid therapy of complications of infectious mononucleosis on the course of Epstein-Barr virus hepatitis

Magdalena Rutkowska, Maria Pokorska-Śpiewak

Clin Exp HEPATOL 2023; 9, 4: 375-385

DOI: https://doi.org/10.5114/ceh.2023.133169

Abstract View text (PDF)

Original paper

N-acetylcysteine acts as a potent anti-inflammatory agent altering the eicosanoid profile in the development of simple steatosis and its progression to hepatitis

Klaudia Sztolsztener, Janusz Dzięcioł, Adrian Chabowski

Clin Exp HEPATOL 2023; 9, 4: 386-395

DOI: https://doi.org/10.5114/ceh.2023.133106

Abstract View text (PDF)

Original paper

Effect of vitamin D supplementation on various parameters in patients with non-alcoholic fatty liver disease: An updated meta-analysis

Dongdong Li, Ningtao Fu, Hui Wu

Clin Exp HEPATOL 2023; 9, 4: 396-404

DOI: https://doi.org/10.5114/ceh.2023.133194

Abstract View text (PDF)

Short report

Increased aminotransferases do not necessarily mean hepatotoxicity of CFTR modulator therapy

Marek Woynarowski, Ewa Sapiejka, Maria Jóźwiak, Aldona Wierzbicka-Rucińska

Clin Exp HEPATOL 2023; 9, 4: 405-409

DOI: https://doi.org/10.5114/ceh.2023.132264

Abstract View text (PDF)

Porto-sinusoidal vascular disease: a new definition of an old clinical entity

The role of microRNAs in hepatocellular carcinoma: Therapeutic targeting of tumor suppressor and oncogenic genes

Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure

Does amyloid b precursor protein gene expression have a role in diagnosis of biliary atresia?

Concomitant diverticulosis among patients undergoing liver transplantation. Does it influence the length of hospitalization after the procedure?

Comparison of intravenous terlipressin infusion versus bolus in patients with acute-on-chronic liver failure–acute kidney injury – an open label RCT

Methotrexate-induced hepatotoxicity in rats and the therapeutic properties of vitamin E: a histopathologic and flowcytometric research

Thrombospondin-2 as a potential noninvasive biomarker of hepatocyte injury but not liver fibrosis in children with MAFLD: A preliminary study

The influence of steroid therapy of complications of infectious mononucleosis on the course of Epstein-Barr virus hepatitis

N-acetylcysteine acts as a potent anti-inflammatory agent altering the eicosanoid profile in the development of simple steatosis and its progression to hepatitis

Effect of vitamin D supplementation on various parameters in patients with non-alcoholic fatty liver disease: An updated meta-analysis

Increased aminotransferases do not necessarily mean hepatotoxicity of CFTR modulator therapy

Coverage in

Integrated with

Editorial Policies